NCT06908538 Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain
| NCT ID | NCT06908538 |
| Status | Recruiting |
| Phase | — |
| Sponsor | AtriCure, Inc. |
| Condition | Amputation |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2035-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2025-04-01 with a primary completion date of 2035-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this Registry is to see how the device is used when freezing nerves during an amputation procedure.
Eligibility Criteria
Inclusion Criteria: * Patients who have or will have an amputation procedure; * Patients who are willing and capable of providing informed consent; * Patients whose age is 18 years or above, or of legal age to give informed consent specific to state and national law. Exclusion Criteria: * Women of childbearing potential who are, or plan to become, pregnant during the time of the study; * Other medical, social, or psychological conditions that in the opinion of the Investigator precludes the subject from appropriate consent or adherence to the protocol.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06908538 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Amputation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06908538 currently recruiting?
Yes, NCT06908538 is actively recruiting participants. Contact the research team at CryoNB-registry@atricure.com for enrollment information.
Where is the NCT06908538 trial being conducted?
This trial is being conducted at Pittsfield, United States, Manchester, United States, New York, United States, Columbus, United States and 1 additional location.
Who is sponsoring the NCT06908538 clinical trial?
NCT06908538 is sponsored by AtriCure, Inc.. The trial plans to enroll 2,000 participants.